citrulline has been researched along with idarubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blijlevens, NM; Buurman, WA; Derikx, JP; Donnelly, JP; Fujii, H; Heineman, E; Kanda, T; van Bijnen, AA | 1 |
1 other study(ies) available for citrulline and idarubicin
Article | Year |
---|---|
Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients.
Topics: Adult; Aged; Antineoplastic Agents; Carrier Proteins; Citrulline; Cohort Studies; Cyclophosphamide; Enterocytes; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Longitudinal Studies; Male; Membrane Glycoproteins; Middle Aged; Molecular Weight; Mucositis; Reference Standards; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 2009 |